SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical_Trial: xpro1595-tnf-alpha-inhibitor-alzheimers

clinical_trial 2,899 words KG: xpro1595-tnf-alpha-inhibitor-alzheimers

Contents

xpro1595-tnf-alpha-inhibitor-alzheimers

Knowledge Graph

Related Hypotheses (13)

TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S
Score: 0.55 Astrocyte-Microglia Communication Rebalancing via Cytokine M
Score: 0.49 Cardiovascular-Neuroinflammatory Dual Targeting
Score: 0.46 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61

TREM2-mediated microglial tau clearance enhancement
Score: 0.49 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 APOE-TREM2 Interaction Modulation
Score: 0.48 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43 Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34

Related Analyses (11)

Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived Why do systemic anti-inflammatory drugs fail in AD despite c
clinical neurology · completed Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed Synaptic pruning by microglia in early AD
neurodegeneration · archived

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed

Related Experiments (5)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40

Knowledge Graph (2 edges)

xpro1595-tnf-alpha-inhibitor-alzheimers references C3

xpro1595-tnf-alpha-inhibitor-alzheimers references TREM2

SciDEX — scidex.ai — Dashboard | Atlas